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Abstract
We recently proposed a new strategy: 2-locus TDT for detecting two susceptibility genes through
their interaction in trio families. We apply our method to two candidate genes, A and C, on the
Genetic Analysis Workshop 15 (GAW15) simulated rheumatoid arthritis data and study the power
to identify an interactive effect of these genes.
This study was performed with full knowledge of the answers.
Introduction
Most multifactorial diseases result from complex interac-
tions among multiple genes with modest effects and vari-
ous environmental factors. Current strategies usually aim
to detect the individual effect of each factor.
We have recently proposed a new strategy: the 2-locus
TDT (transmission-disequilibrium test), which tests for
interaction between two candidate genes [1]. Like the one-
locus TDT [2], it applies to trio families including the
patient and his two parents. Our method is used in the
context of studying good candidate pathways. Indeed, we
assume prior information that the disease under study is
probably caused by particular genes recognized as key ele-
ments of the metabolic pathway. We apply the 2-locus
TDT to Problem 3 simulated Genetic Analysis Workshop
15 (GAW15) rheumatoid arthritis (RA) data and compute
its power for detecting the interaction of two susceptibility
genes.
Data
The GAW15 Problem 3 consisted of 100 replicates of
1500 nuclear families with two affected sibs. From each
replicate, we extracted 1500 trio families: one affected (the
index case) and his two parents.
We focus the analyses on two candidate genes in the RA
susceptibility: Locus A on chromosome 16 and Locus C
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St. Pete Beach, Florida, USA. 11–15 November 2006
Published: 18 December 2007
BMC Proceedings 2007, 1(Suppl 1):S65
<supplement> <title> <p>Genetic Analysis Workshop 15: Gene Expression Analysis and Approaches to Detecting Multiple Functional Loci</p> </title> <editor>Heather J Cordell, Mariza de Andrade, Marie-Claude Babron, Christopher W Bartlett, Joseph Beyene, Heike Bickeböller, Robert Culverhouse, Adrienne Cupples, E Warwick Daw, Josée Dupuis, Catherine T Falk, Saurabh Ghosh, Katrina A Goddard, Ellen L Goode, Elizabeth R Hauser, Lisa J Martin, Maria Martinez, Kari E North, Nancy L Saccone, Silke Schmidt, William Tapper, Duncan Thomas, David Tritchler, Veronica J Vieland, Ellen M Wijsman, Marsha A Wilcox, John S Witte, Qio g Yang, Andreas Ziegler, Laura Almasy a d Jean W MacCluer</editor> <note>Proce dings</note> <url>http://www.biomedc ntral.com/content/pdf/1753-6561-1-S1-info.pdf</url> </supplement>
This article is available from: http://www.biomedcentral.com/1753-6561/1/S1/S65
© 2007 Kotti et al; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 4
(page number not for citation purposes)
BMC Proceedings 2007, 1(Suppl 1):S65 http://www.biomedcentral.com/1753-6561/1/S1/S65on chromosome 6. Locus A has an indirect effect on RA
hazard. Its implication on the susceptibility to the disease
depends on the HLA-DRB1 locus located on chromosome
6. Locus C is in strong linkage disequilibrium (LD) with
HLA-DRB1. Both genes are involved directly or indirectly
in the RA outcome through the HLA-DRB1 gene and thus
do not act independently. We apply the 2-locus TDT to the
SNPs indicated as functional in the two candidate genes in
each replicate of 1500 trios.
Notation
We denote A1, A2 and C1, C2 the SNP alleles of genes A and
C, respectively. For each patient, there are nine possible
genotypes that we denote AiAjCkCl, where Ai, Aj and Ck, Cl
are the alleles inherited from the two parents at the loci A
and C, respectively. Subscripts i, j, k and l can be either 1
or 2. A2 and C2 are considered to be the high risk alleles
and A2A2C2C2 are the reference genotype.
We denote the nine penetrances P(affected | AiAjCkCl) by
fijkl and by εijkl the eight penetrances relatively to the refer-
ence genotype A2A2C2C2. Thus, ε2222 = 1. Let MG be the
general model in which εijkl may take any value between 0
and 1. When the two genes A and B act independently, the
lines and the columns of the relative penetrance matrix
are proportional (multiplicative matrix) and may be writ-
ten with four parameters: μ, ν, ϕ and π (see Table 1). The
corresponding restricted model is denoted MR.
Method
The 2-locus TDT is achieved in two steps. In the first step,
the parameters (μ, ν, ϕ, and π) of the restricted model and
εijkl of the general model are estimated by their maximum
likelihood estimator (MLE). In the second one, the
restricted model is compared to the general one by a max-
imum likelihood ratio test.
The estimation of these parameters requires specifying the
allele frequencies at each locus. This was achieved by the
affected family-based controls (AFBAC) method, using
the parental alleles untransmitted to the patients from
which the family was ascertained [3]. Here, the families
were not ascertained through an affected patient but
through a patient with an affected sib. Our parameter esti-
mation must also take into account this specific mode of
ascertainment and consequently was achieved by using
the marker association segregation chi-square (MASC)
program [4].
We denote by maxGLG and maxRLR the likelihood values
for the estimated parameters of the general and restricted
models, respectively. The likelihood ratio test (LRT) was
calculated as follows:
This ratio follows, under the null hypothesis, a chi-square
distribution with four degrees of freedom (df) corre-
sponding to the difference in the number of parameters
between the two models.
For each replicate of 1500 trios, the LRT was computed
and the significance of the test was assessed in order to
evaluate the power of our test in the present situation.
Results
Because patients with genotypes A1A1C1C1, A1A2C1C1,
and A2A2C1C1 are very rare in all replicates, we fixed the
relative penetrances of these genotypes at 10-3. Conse-
quently, under the general model, we estimate only five
parameters and, under the restricted model, only three
parameters ν, ϕ, and π. Thus, in the present situation, we
have 2 degrees of freedom for the LRT. Figures 1 and 2
show the distributions of the LRT and p-values in 98 rep-
licates (the program failed in 2 replicates), respectively.









Distribution of the LRT valuesFigure 1
Distribution of the LRT values.
Table 1: Penetrance estimation under the restricted model
Gene A
Gene C A1A1 A1A2 A2A2
C1C1 ϕμ πμ μ
C1C2 ϕν πν ν
C2C2 ϕ π 1Page 2 of 4
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TDT test (at a 5% level) is 66%.
We illustrate the variation of the LRT and p-values on two
contrasting replicates: 9 and 27. In the Replicate 27, there
is a strong evidence for interaction: LRT = 14.35 and p = 7
× 10-4. In contrast, we did not find interaction in Replicate
9 because the LRT = 2.49 and p = 0.29.
Tables 2 and 3 show the parameter estimates under the
general model for Replicates 9 and 27, respectively. The
parameter estimates under the restricted model are ν =
0.135, ϕ = 0.688, and π = 0.886 for Replicate 9 and ν =
0.168, ϕ = 0.682, and π = 0.909 for replicate 27. It is clear
that the departure from multiplicativity in the relative
penetrance matrix of the general model is stronger for
Replicate 27 than for Replicate 9. In particular, for Repli-
cate 27, the relative penetrance for the genotype A1A2C2C2
is half of the one expected under the restricted model.
Discussion
In this paper, we studied the performance of the 2-locus
TDT for detecting the interaction of the genes A and C in
the susceptibility to RA simulated data and show that
interaction may be detected with a power of 66% at a 5%
level.
The 2-locus TDT searches for a departure from multiplica-
tivity in the two-locus penetrance matrix. This departure
cannot be observed without an effect of the two genes.
Therefore, the 2-locus TDT may also be used for detecting
the effect of two candidate genes through their interac-
tion.
More generally, the 2-locus TDT may be particularly inter-
esting in the situation of weak effect of one or both genes
and strong interaction. In such a situation, traditional
methods will fail because they will stop in the absence of
noticeable main effect. In fact, they ignore the possibility
that the interactive effect of multilocus functional genetic
variants may play a larger role than the single-locus effect
in the determinism of one trait [1].
Our test applies to candidate genes already recognized as
key elements of a metabolic pathway thought to be
involved in the disease pathogenesis. There are difficulties
in good candidate choice and the use of tagSNPs as mark-
ers for most genetic variations in the human genome has
become a cornerstone of genetic research. There are, how-
ever, reasons to think that the expectations they have
raised are somewhat inflated and may lead to unwar-
ranted neglect of other strategies. In particular, we believe
in particular that identification of biologically relevant
pathways followed by candidate gene strategies may be
quite effective at identifying new variants and their inter-
action in disease susceptibility [5].
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Table 3: Replicate 27: Matrix of relative penetrances for the 
general model
Gene A
Gene C A1A1 A1A2 A2A2
C1C1 0.001 0.001 0.001
C1C2 0.137 0.133 0.083
C2C2 0.623 0.868 1
a Bold indicates parameter estimates.
Distribution of the LRT p-valuesFigure 2
Distribution of the LRT p-values.
Table 2: Replicate 9: Matrix of relative penetrances for the 
general model
Gene A
Gene C A1A1 A1A2 A2A2
C1C1 0.001 0.001 0.001
C1C2 0.105a 0.109 0.113
C2C2 0.668 0.879 1
a Bold indicates parameter estimates.Page 3 of 4
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